SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma.
Wan S, He QY, Yang Y, Liu F, Zhang X, Guo X, Niu H, Wang Y, Liu YX, Ye WL, Li XM, ZhuanSun XM, Sun P, He XS, Hu G, Breuhahn K, Zhao H, Wu GQ, Wu H.
Wan S, et al. Among authors: zhuansun xm.
Cancer Res. 2024 Jun 4;84(11):1872-1888. doi: 10.1158/0008-5472.CAN-23-2889.
Cancer Res. 2024.
PMID: 38471084